Skip to main
NVCR
NVCR logo

Novocure (NVCR)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Novocure (NVCR) Stock

About Novocure (NVCR)

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jer...read more
Market cap$1.98B
Today's volume1.17M
Revenue (TTM)$621.71M
Avg. daily volume1.22M
EBITDA (TTM)-$154.17M
Open$17.60
Price / earnings ratio-11.78x
Today's range$17.53 - $18.61
Debt / equity192.49x
52 week range$14.17 - $34.13
5 year debt / equity112.56x
Beta (LTM)1.26x
Interest coverage-14.37x
Dividend & yield$0.00 (0.00%)
Current ratio1.47x
Ex-dividend date
Next earningsJul 24, 2025
Dividend payable date

Novocure Stock Rating

What analysts recommend for NVCR stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 25%
Buy 44%
Hold 25%
Sell 6%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for Novocure stock is $1.99B

The current P/E ratio for Novocure stock is -11.78

The 52-week high for Novocure stock is $34.13. The current Novocure stock price $undefined is 100.00% below its 52-week high

The 52-week low for Novocure stock is $14.17. The current Novocure stock price $undefined has increased 100.00% from its 52-week low

No, the Novocure stock does not pay dividends to its shareholders

The target price for Novocure stock is $77.69 based on the average of what a group of analyst think Novocure stock could be worth at a future date. This is not a prediction by Public.com

How to buy Novocure stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Novocure stock

    Navigate to the Explore page. Then, type Novocure into the search bar. When you see Novocure stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Novocure stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Novocure Stock Earnings

The value each NVCR share was expected to gain vs. the value that each NVCR share actually gained.

Novocure (NVCR) reported Q1 2025 earnings per share (EPS) of -$0.31, beating estimates of -$0.46 by 32.61%. In the same quarter last year, Novocure's earnings per share (EPS) was -$0.36. Novocure is expected to release next earnings on 07/24/2025, with an earnings per share (EPS) estimate of -$0.39.

Buy Novocure (NVCR) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.